Ben Zhao is a Founding and Managing Partner of Co-win Ventures.
Ben has over 25 years of management and entrepreneurial experience. His profession in venture capital started in 2002. Before joining Co-win Ventures, Ben worked at Sino-Singapore Venture where he led various investments. Before that, He had held positions of investment manager of Taiwai Yihe Venture and senior software engineer at ZTE. Ben started his career working as an engineer at PLA.
Ben has led and participated in Tongcheng（00780.HK）, Hujiang, Jia.com（01739.HK）, Haier IC, EASTSOFT (300183), Triductor, InnoLight (300308), NewVision (000008), Alae (300585), Diasc (300554), MEMSensing, PIC, and MAX. He is a board member of Tongcheng, Diasc, and InnoLight.
Ben Zhao holds an MBA from Nanjing University and a BS in Computer Science from National University of Defense Technology.
Dr. Xin Huang is a Managing Partner of Co-win Ventures. He started Co-win Ventures' healthcare practice in 2012 and has since led the investments.
Dr. Huang has more than 20 years experience in clinical medicine, translational research, healthcare management consulting and venture capital investment. Prior to joining Co-win Ventures in 2012, Dr. Huang served as a management consultant at BCG and a senior investment manager at Omaha Capital. He has been closely involved with more than 20 start-ups, including PegBio, Aucta Pharm, Connect Pharm, CF PharmTech,CureGenix, 3DMed, SynBio, Howsome, Gemstone Bio, CytekBio, CytoChip, PGDx, PapGene, and etc.
Dr. Xin Huang holds an M.D. from Peking Union Medical College and a Ph.D. from Johns Hopkins University. He was ranked No.1 in the National College Entrance Exam in China in 1995.
Dr. Johnny Sun is a Partner of Co-win Ventures, responsible for risk control and capital operation.
Dr. Sun has more than 20 years of experience in marketing, finance, business management. He started his career in venture capital in 2009. Previously, he served as a partner at ZAFFER and a general manager at Gold Credit Guaranty. Dr. Sun has been involved with more than 20 deals including BoYun new materials (002297), Hzone-Li, ZH-PMI, Even Control, Dewater Tech, Kaitian Environmental Tech, Jiahe agricultural, and etc.
Dr. Johnny Sun holds a Ph. D. in Management from Central South University and is a certified CICPA. He was the vice president of HCGA.
Chunhui Rong is an Investment Director at Co-win Ventures.
Chunhui started his career in 2012. Before joining Co-win Ventures in 2015, he had been investment manager at Nanjing Baoan Venture and customer care specialist at Stago Diagnosis. Chunhui has participated in deals such as Complete Omics, Sinoprecision, Synbio-tech, CF Pharmtech, Suzhou Connect Biopharma, PegBio, Howsome Biotech, and Neighbor Doc etc.
Chunhui Rong holds an MS in Biomedical Engineering and a BS in Laboratory Medicine, both from Southeast University.
Bruce Lin is an Senior Investment Director at Co-win Ventures.
Bruce joined Co-win Ventures in 2016. He started his career in venture capital in 2011. He was a director at Jiangsu Ruihua Holdings, responsible for capital operation. Bruce has led and participated in deals such as InnoLight (300308),MEMSensing,Triductor and Meijun Electronics.
Bruce Lin holds an MBA from Nanjing University.
Winnie joined Cowin Ventures in 2021.Prior to joining Kaifeng Ventures. She had more than 4 years of work experience in MNC such as MSD ,AstraZeneca .Winnie was responsible for the regional marketing of brain tumor products in MSD oncology business unit , keep winning the President's Award 2016-2019.
Winnie holds a Master's degree in Bioinformatics from the University of Chicago , and a Bachelor's degree in Clinical Medicine from Shanghai University of Traditional Chinese Medicine.